Flagship Pioneering — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Generate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering.
AI & Machine LearningBiotechDeep TechSomerville, US
Gevorg Grigoryan(Co-Founder & Chief Technology Officer)in
Co-investorsARCH Venture PartnersMarch Capital PartnersAlaska Permanent Fund CorporationALTITUDE LIFE SCIENCE VENTURESNVenturesT. Rowe Price
BiotechCambridge, US
HOWARD BERNSTEIN(Executive Officer)HOWARD WEISMAN(Executive Officer, Director)
BoardALAN CRANE(Director)ROBERT LANGER(Director)ANUPENDRA SHARMA(Director)HARRY WILCOX(Director)
Co-investorsFlagship VenturesNewpath PartnersPolaris Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.